Cd(II) and Pb(II) complexes of the polyether ionophorous antibiotic salinomycin by Ivanova, Juliana et al.
RESEARCH ARTICLE Open Access
Cd(II) and Pb(II) complexes of the polyether
ionophorous antibiotic salinomycin
Juliana Ivanova
1, Ivayla N Pantcheva
2, Mariana Mitewa
2, Svetlana Simova
3*, Makoto Tanabe
4 and Kohtaro Osakada
4
Abstract
Background: The natural polyether ionophorous antibiotics are used for the treatment of coccidiosis in poultry
and ruminants. They are effective agents against infections caused by Gram-positive microorganisms. On the other
hand, it was found that some of these compounds selectively bind lead(II) ions in in vivo experiments, despite so
far no Pb(II)-containing compounds of defined composition have been isolated and characterized. To assess the
potential of polyether ionophores as possible antidotes in the agriculture, a detailed study on their in vitro
complexation with toxic metal ions is required. In the present paper we report for the first time the preparation
and the structure elucidation of salinomycin complexes with ions of cadmium(II) and lead(II).
Results: New metal(II) complexes of the polyether ionophorous antibiotic salinomycin with Cd(II) and Pb(II) ions
were prepared and structurally characterized by IR, FAB-MS and NMR techniques. The spectroscopic information
and elemental analysis data reveal that sodium salinomycin (SalNa) undergoes a reaction with heavy metal(II) ions
to form [Cd(Sal)2(H2O)2]( 1) and [Pb(Sal)(NO3)] (2), respectively. Abstraction of sodium ions from the cavity of the
antibiotic is occurring during the complexation reaction. Salinomycin coordinates with cadmium(II) ions as a
bidentate monoanionic ligand through the deprotonated carboxylic moiety and one of the hydroxyl groups to
yield 1. Two salinomycin anions occupy the equatorial plane of the Cd(II) center, while two water molecules take
the axial positions of the inner coordination sphere of the metal(II) cation. Complex 2 consists of monoanionic
salinomycin acting in polydentate coordination mode in a molar ratio of 1: 1 to the metal ion with one nitrate ion
for charge compensation.
Conclusion: The formation of the salinomycin heavy metal(II) complexes indicates a possible antidote activity of
the ligand in case of chronic/acute intoxications likely to occur in the stock farming.
Background
The natural polyether ionophorous antibiotics produced
by Streptomyces spp. are used for the treatment of cocci-
diosis in poultry (chickens, turkeys and quail) and rumi-
nants (cattle, sheep and goats). They are agents
controlling ketosis and bloat in cattle and are applied as
growth promoter feed additives in cattle and sheep. The
polyether ionophores are mainly effective against Gram-
positive bacteria, interfering with ion flux across bacter-
ial membranes thus causing reallocation of bacterial
energy resources to maintain cellular pH and ion bal-
ance. Effects on feed conversion efficiency arise from
the ability of antibiotics to shift rumen fermentation
towards the more energetically efficient propionate path-
way, to reduce methane production and to increase
nitrogen retention by reducing dietary protein deamina-
tion and urinary ammonia excretion [1-9].
From chemical point of view these compounds are
polyether derivatives of monocarboxylic acids and
represent potential ligands able to bind metal cations
due to the presence of oxygen atoms of various types
(carboxylic, ether, hydroxyl) in the antibiotic mole-
cule. Monensin, salinomycin, narasin etc. are best
known as monovalent polyether ionophores for their
affinity to complex with alkali ions, Ag
+ and Tl
+
[10-22]. Recently we have shown that they react also
with metal(II) ions to form complexes of different
composition and of various coordination mode of the
ligands [23-28]. Due to their enhanced cytotoxicity
against Gram-positive microorganisms as compared to
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© 2011 Ivanova et althe non-coordinated compounds, the complexes of
monensin and salinomycin with biometal(II) ions
could be discussed as potential antibacterial agents
[23-27]. These new compounds (especially the salino-
mycin complexes) exert also a pronounced antitumor
activity against cell lines established from various
malignancies (Ivanova J, Pantcheva IN, Zhorova R,
M o m e k o vG ,S i m o v aS ,S t o y a n o v aR ,Z h e c h e v aE ,I v a -
nova S, Mitewa M: Synthesis, spectral properties, anti-
bacterial and antitumor activity of salinomycin
complexes with Co(II), Ni(II), Cu(II) and Zn(II) transi-
tion metal ions, unpublished), [29,30].
O nt h eo t h e rh a n d ,i tw a sf o u n dt h a ts o m ep o l y e t h e r
ionophores as monensin, ionomycin and nigericin
selectively bind lead(II) although the Pb(II)-containing
complex species were not isolated and characterized
[31-33]. It has been shown that monensin significantly
improves the effectiveness of the traditional antidote
DMSA (dimercaptosuccinic acid) in reducing Pb(II)
concentration in brain and bones of rats, intoxicated
with a Pb(II) salt [34]. We recently reported that mon-
ensic acid (MonH) reacts with Cd(II) and Hg(II) ions
to form stable complex compounds with different
coordination mode of the ligand [28]. Our studies with
an animal model (ICR male mice) proved the ability of
monensin to act as an efficient antidote in cases of
subchronic cadmium intoxication. In contrast to
DMSA and EDTA, monensin significantly reduces cad-
mium(II) concentration in mice organs, subjected to
subchronic intoxication, when applied as tetraethyl
ammonium salt, without affecting the homeostasis of
Cu(II) and Zn(II) ions (Ivanova J, Gluhcheva Y, Kame-
nova K, Ganeva S, Mitewa M: Tetraethyl ammonium
salt of monensic acid decreases cadmium concentra-
tion in organs of mice subjected to subchronic cad-
mium intoxication, unpublished). These findings prove
the necessity of an extensive study on in vitro com-
plexation of polyether ionophorous antibiotics with
toxic metal ions. A preliminary assessment of their
potential as chelating agents will considerably facilitate
the treatment of intoxication with toxic metal ions. To
the best of our knowledge until now no information
on the ability of salinomycin to form complexes with
Cd(II), Pb(II) and Hg(II) has been published. In the
present paper we report for the first time the prepara-
tion and the structure characterization of salinomycin
complexes with ions of cadmium(II) and lead(II). As a
starting material the commercially available sodium
form of salinomycin (SalNa) was used. Extensive NMR
data in CDCl3,D M S O - d 6 and in isotropic bicelles have
been published for this compound [35-37]. The new
complexes isolated are analyzed and characterized by
IR, FAB-MS, NMR spectroscopies and elemental analy-
sis data.
Results and Discussion
Complexation of salinomycin (Scheme 1) with ions of
Cd(II) and Pb(II) proceeds at mild conditions in the
absence of additives and at metal-to-ligand molar ratio
= 2: 1. The isolation and characterization of the new
compounds confirm the ability of polyether ionophores
to react with toxic metal(II) cations and to produce
mononuclear complex species. Contrary to sodium
monensin (MonNa), which forms heterometallic com-
plexes of composition [M(MonNa)2Cl2]( M=C o ,M n ,
Cu) [23,25], sodium salinomycin (SalNa) produces only
homometalic complexes [M(Sal)2(H2O)2]( M=C o ,N i ,
Cu, Zn) where the sodium ions are abstracted from the
ligand cavity (Ivanova J, Pantcheva IN, Zhorova R,
M o m e k o vG ,S i m o v aS ,S t o y a n o v aR ,Z h e c h e v aE ,I v a -
nova S, Mitewa M: Synthesis, spectral properties, anti-
bacterial and antitumor activity of salinomycin
complexes with Co(II), Ni(II), Cu(II) and Zn(II) transi-
tion metal ions, unpublished).
Despite the use of different techniques (slow evapora-
tion of single solvents; slow evaporation of multi solvent
systems, slow diffusion method) our efforts to grow
crystals from the new compounds were not successful.
Only plate-like crystals were obtained which were not
appropriate for a refinement of the structures of the
new complexes by X-ray diffraction method. This is not
s u r p r i s i n gs i n c el i t e r a t u r ed a t ai n d i c a t et h a ti nc o n t r a s t
to other polyether ionophorous antibiotics, salinomycin
and its metal derivatives do not easily crystallize. It
should be pointed out that up to now only two crystal
structures of salinomycin derivatives are published
[11,20]. In order to become acquainted with the struc-
ture of the new complexes of this compound with Cd
(II) (1) and Pb(II) (2) ions their properties were studied
by IR, NMR and FAB-MS spectroscopies.
Scheme 1 Structural formula and numbering sequence (carbon
and oxygen atoms) of salinomycinic acid.
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Page 2 of 8Due to the similar coordination mode of the ligand in
its sodium and in the presently investigated metal
forms, the main bands of the coordinated groups in the
IR spectra of complexes 1 and 2 do not significantly
change as compared to the spectrum of sodium salino-
mycin. The stretching vibrations of the hydroxyl groups
in the spectra of 1 and 2 are both observed at 3380 cm
-
1 in analogy to the broad band at 3400-3300 cm
-1 in the
spectrum of SalNa. The two bands at 1550 cm
-1/1410
cm
-1 (1) and at 1520 cm
-1/1410 cm
-1 (2) for the depro-
tonated carboxylic function are assigned to the asym-
metric and symmetric COO-vibrations, respectively. The
new intensive band at 1300 cm
-1 in the spectrum of the
Pb(II) complex (2) can be attributed to the presence of
nitrate ions originating from the initial lead(II) salt.
The structure of complexes 1 and 2 in solution is cor-
roborated by the unambiguous assignment of their pro-
ton and carbon-13 NMR spectra. The data obtained are
compared with those observed for acidic (SalH) and
sodium (SalNa) forms of salinomycin. The
1H-NMR
chemical shifts are listed in the Experimental Section;
1H- and
13C-NMR spectra are placed in Figure 1 and 2,
respectively. Chemical shifts for carbon-13 atoms are
presented in Table 1, following the numbering of salino-
mycin shown in Scheme 1.
Comparison of the proton and carbon-13 chemical
shifts of the complexes with the data for SalH and
SalNa confirm that both 1 and 2 remain intact in aceto-
nitrile solution. Characteristic is the downfield
13C shift
by approx. 7 ppm of the deprotonated carboxylic carbon
atom. The chemical shifts of most carbon atoms in the
four compounds do not change significantly and are in
a narrow range of ± 0.5 ppm. However, several observed
down- and upfield shifts of 1 to 3 ppm in the spectra of
1-2 indicate that the new compounds possess slightly
different conformations in solution when compared to
both salinomycinic acid and its sodium complex.
The FAB-MS spectra confirm the presence of toxic
metal(II) ions in the corresponding complexes 1 and 2
(Figure 3). The spectrum of complex 1 contains eight
1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 ppm
SalH
SalNa
SalCd
SalPb
Figure 1
1H-NMR spectra of salinomycinic acid, sodium salinomycin and complexes 1-2.
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Page 3 of 8peaks assigned to the formation of [C42H69O11Cd]
+ (1a)
(calc. m/z = 863, 100%; m/z = 861, 83.5%; m/z = 862,
67.7%; m/z = 860, 49.2%; m/z = 864, 42.4%; m/z = 859,
32.9%; m/z = 865, 30.9%; m/z = 866, 11.7%). The FAB-
MS spectrum of complex 2 consists of peaks attributed
to [C42H69O11Pb]
+ (2a)( calc.m / z=9 5 7 ,1 0 0 % ;m / z=
956, 46.7%; m/z = 955, 33.6%). The obtained isotopic
patterns of 1 and 2 as shown in Figure 3 are consistent
with the calculated peaks. It should be noted that the
toxic metal(II) species are very stable in the gas phase
and no formation of sodium-containing ions
[C42H70O11Na]
+ was observed compared to the beha-
viour of other salinomycin complexes known up to now
(Ivanova J, Pantcheva IN, Zhorova R, Momekov G,
Simova S, Stoyanova R, Zhecheva E, Ivanova S, Mitewa
M: Synthesis, spectral properties, antibacterial and anti-
tumor activity of salinomycin complexes with Co(II), Ni
(II), Cu(II) and Zn(II) transition metal ions,
unpublished).
On the basis of the spectroscopic studies and elemen-
tal analysis evidence, it can be concluded that sodium
salinomycin reacts with ions of Cd(II) and Pb(II) to
form coordination compounds with different composi-
tion and structure. It was found that cadmium(II) ion
reacts with two carboxylate anions of salinomycin,
extracting sodium ions from the cavity of the starting
compound. Salinomycinate monoanions are bound to
the metal(II) center in a bidentate coordination mode
via terminal deprotonated carboxylic group and terminal
hydroxyl group achieving head-to-tail cyclization. Most
probably oxygens atoms O-1 (carboxylate) and O-28
(secondary hydroxyl) occupy the equatorial places in the
inner coordination sphere of the metal(II) ion. Two axi-
ally located aqua molecules could stabilize the pseudo-
cyclization of the complex. Cadmium(II) disalinomyci-
nate (1) is expected to possess a distorted octahedral
geometry similarly to the structures reported for the
complexes of salinomycin with ions of Co(II), Ni(II), Cu
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
SalH
SalNa
SalCd
SalPd
Figure 2
13C-NMR spectra of salinomycinic acid, sodium salinomycin and complexes 1-2.
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Page 4 of 8(II) and Zn(II) (Ivanova J, Pantcheva IN, Zhorova R,
M o m e k o vG ,S i m o v aS ,S t o y a n o v aR ,Z h e c h e v aE ,I v a -
nova S, Mitewa M: Synthesis, spectral properties, anti-
bacterial and antitumor activity of salinomycin
complexes with Co(II), Ni(II), Cu(II) and Zn(II) transi-
tion metal ions, unpublished).
In contrast to Cd(II), Pb(II) ions react with sodium
salinomycin, extracting sodium ions from the ligand
cavity, but forming complex 2 of a composition [Pb(Sal)
(NO3)]. The extremely low solubility of this compound
in water suggests that the nitrate ion is most probably
coordinated in the inner coordination sphere of the
metal center. The registered downfield shifts for C1, C2,
Table 1
13C-NMR chemical shifts (150 MHz, acetonitrile-
d3) of salinomycinic acid (SalH), sodium salinomycin
(SalNa) and complexes 1-2
C-atom SalH SalNa 1 2
11C = O 215.53 220.23 216.77 215.75
1COOH 177.86 185.06 184.98 184.60
19CH = 133.65 130.58 132.59 133.03
18CH = 123.43 123.57 122.23 123.95
*21C 107.72 107.52 107.44 108.96
*17C 100.14 100.00 100.24 99.99
*24C 89.04 89.20 88.84 89.33
29CH 77.83 77.88 78.14 78.11
13CH 78.60 76.87 78.76 77.41
3CH 75.51 76.99 76.84 75.24
25CH 75.05 75.11 74.67 76.05
7CH 72.73 72.12 72.13 72.30
*28C 71.47 70.8 71.87 73.74
9CH 69.89 69.24 69.63 70.60
20CH 68.10 67.46 67.70 67.22
12CH 56.80 56.55 57.28 54.58
2CH 49.25 51.62 49.24 55.08
10CH 49.09 49.91 48.69 49.59
16CH 41.42 41.48 41.73 41.74
15CH2 39.09 39.16 39.39 38.90
22CH2 37.49 38.10 36.57 36.64
8CH 37.06 36.76 36.92 36.43
14CH 33.66 33.44 33.89 33.55
23CH2 31.53 33.15 32.37 33.91
31CH2 31.92 32.86 32.09 31.92
27CH2 30.19 29.57 30.24 30.47
6CH 29.06 28.94 29.15 28.97
33CH3 26.03 27.76 26.07 28.97
5CH2 26.94 27.43 27.13 27.02
41CH2 23.47 24.17 23.56 24.85
26CH2 22.72 20.42 22.41 20.47
4CH2 20.77 20.72 21.16 21.50
35CH3 17.86 17.87 18.19 17.95
36CH2 18.68 16.20 19.39 17.02
34CH3 15.99 16.29 16.07 16.06
30CH3 15.31 15.12 15.24 14.8
38CH3 13.47 12.94 13.70 13.34
37CH3 14.15 13.31 14.09 13.81
42CH3 12.20 12.94 12.71 13.01
40CH3 11.65 11.27 12.09 11.59
39CH3 7.83 7.18 7.97 7.48
32CH3 6.79 6.87 6.94 6.83
Figure 3 FAB-MS spectra of complexes 1 (a) and 2 (b).
Scheme 2 Proposed structures of a) [Cd(Sal)2(H2O)2] (1) and of
b) [Pb(Sal)(NO3)] (2).
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Page 5 of 8C23, C28 and C33, and upfield shifts for C12, C13 and
C26 in the
13C-NMR spectrum of Pb(II) salinomycinate
as compared with the spectra of SalH and SalNa suggest
coordination of the carboxylate oxygen O-1a, of the
hydroxyl oxygen O-28 and the ether oxygens O-3 and
O-24 to the Pb(II) ion. The coordination of nitrate
anion at axial position in the inner coordination sphere
of the metal center secures the overall neutral charge of
the complex. It should be noted that the observed
enhancements in the NOESY spectra of complexes 1-2
confirm the different metal-to-ligand stoichiometry. The
positive NOE’s for all signals in 2 indicate formation of
1:1 complex with a lower molecular mass while the
negative NOE’s observed for 1 corroborate the 1:2 stoi-
chiometry, corresponding to a molecular mass higher
than 1500 D.
The different complexation modes of the ligand to
ions of Cd(II) and Pb(II) compared to the coordination
of salinomycin to sodium ions is corroborated by the
chemical shift differences for most carbon atoms in the
corresponding
13C-NMR spectra. The proposed struc-
tures of complexes 1 and 2, derived indirectly on the
basis of their spectral properties are shown on Scheme
2a and Scheme 2b, respectively.
Conclusions
Metal(II) complexes of salinomycin with ions of Cd(II)
and Pb(II) were prepared and characterized in gas phase
( F A B - M S ) ,i ns o l u t i o n( N M R )a n di ns o l i ds t a t e( I R ) .
The data reveal that sodium salinomycin forms homo-
metallic mononuclear complexes, where sodium ions are
abstracted from the cavity of the ligand. Two monoa-
nions of salinomycin occupy four places in the inner
coordination sphere of the Cd(II) ions in the complex 1
with a composition [Cd(Sal)2(H2O)2]w i t ht w ow a t e r
molecules coordinated at axial positions. Contrary to Cd
(II) disalinomycinate, the complex of salinomycin with
Pb(II) ions (2) is of a composition [Pb(Sal)(NO3)] and is
in accordance with a square pyramidal geometry. The
formation of [Cd(Sal)2(H2O)2] and [Pb(Sal)(NO3)] com-
plexes proceeds at mild conditions referring to the prac-
tical application of salinomycin as potential antidote in
case of intoxications with toxic metal ions occurring in
poultry and in ruminants.
Experimental and Methods
Physical measurements
Elemental analysis data (C, H, O) were obtained with
VarioEL V5.18.0 Elemental Analyzer (Germany). The
metal content was determined by AAS on a Perkin
Elmer 1100 B (USA) apparatus using stock standard
solution (1000 mg/mL, Merck). Working reference solu-
tions were prepared after suitable dilution.
IR spectral analysis (in a nujol mull) was performed
on a Specord 75-IR (Carl-Zeiss, Germany). FAB-mass
analysis data were registered using JEOL JMS-700
(JEOL, Japan).
1H (600.13 MHz) and
13C (150.92
MHz) NMR spectra were acquired on an AVANCE
AV600 II+ NMR spectrometer (Bruker, Germany). All
spectra were recorded in acetonitrile-d3 at room tem-
perature (293.0 ± 0.1
0). The residual methyl solvent
signal was used as an internal standard for the
1H
(1.94 ppm) and
13C spectra (1.40 ppm). Unambiguous
assignment of the signals was made on the basis of
the gradient enhanced versions of COSY, TOCSY,
HSQC, HMBC and ROESY experiments (Bruker pulse
library programs: cosygpmfqf, dipsi2etgpsi, hsqce-
detgpsisp2.2, hmbcgplpnd q f ,r o e s y p h . 2 ,2 0 0 7 ) .T h e
chemical shift values of the protons with overlapping
signals in the complexes have been determined from
the HSQC spectra (Figures S1 and S2 [see Additional
files 1 and 2]).
Materials
All chemicals used were of reagent grade. Sodium sali-
nomycin was supplied from Biovet Ltd. (Bulgaria). Cd
(CH3COO)2.2H2Oa n dP b ( N O 3)2.H2O were purchased
from Fluka (Switzerland). Acetonitrile (MeCN), MeOH
and HCl were received from Merck (Germany). In all
experiments deionized water was used.
Synthesis of [Cd(C42H69O11)2(H2O)2] (1)
To a solution of C42H69O11Na (0.25 mmol, 193 mg in
2m LH 2Oa n d2 0m LC H 3CN) Cd(CH3COO)2.2H2O
(0.5 mmol, 135 mg in 2 mL H2O) was slowly added.
The colourless reaction mixture was stirred for 15
min. The solution was concentrated at room tempera-
ture (r.t.) for 7 days to produce white precipitates of
composition [Cd(C42H69O11)2(H2O)2]( 1). The same
reaction occurs also in mixed solvent system MeCN:
MeOH = 1:10. The solid phase was filtered off, washed
with H2O and dried at r.t. The complex is soluble in
MeOH, MeCN, CHCl3 and is not soluble in H2O.
Yield 140 mg, 68%. Anal. Calcd. for C84H142O24Cd (%):
H, 8.68; C, 61.20; Cd, 6.82. Found: H, 8.14; C, 60.51;
Cd, 6.95.
1H-NMR (600.13 MHz, δ (assignment), aceto-
nitrile-d3) 6.06 (18CH), 5.84 (19CH), 4.09 (9CH), 4.04
(20CH), 3.90 (3CH), 3.85 (29CH), 3.72 (7CH), 3.65
(13CH), 3.63 (25 CH), 2.99 (10CH), 2.91 (2CH), 2.67
(12CH), 2.28 (22CH2’), 2.15 (23CH2’), 1.94 (36CH2’),
1.88 (22CH2“), 1.83 (4CH2’,5 C H 2’,6 C H ) ,1 . 8 0( 2 3
CH2’), 1.78 (14CH), 1.68 (26 CH2’), 1.65 (27CH2’), 1.62
(16CH), 1,58 (27CH2“), 1.57 (26CH2’), 1.56 (15CH2’),
1.49 (8CH), 1.48 (4CH2“), 1.46 (33CH3), 1.43 (41CH2’),
1.40 (36CH2“), 1,39 (5CH2“), 1.31 (41CH2“), 1.30
(31CH2), 1.21 (30CH3), 1.09 (15CH2“), 0.91 (40CH3),
0.87 (35CH3,4 2 C H 3), 0.86 (32CH3), 0.80 (37CH3,
38CH3), 0.73 (39CH3), 0.68 (34CH3).
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Pb(NO3)2.H2O (0.5 mmol, 165 mg) was dissolved in 4
mL H2O and was slowly mixed with a solution of
sodium salinomycin (0.25 mmol, 193 mg in 22 mL
mixed solvent (H2O: MeCN = 1: 10)) and the reaction
mixture was stirred for 15 min at room temperature.
T h es o l v e n tw a ss l o w l ye v a p o r a t e d( 7d a y s )t og i v et h e
complex [Pb(C42H69O11)(NO3)] (2) as white precipitates.
The compound was washed with H2Oa n dd r i e da t
room temperature. Yield 190 mg, 75%. Anal. Calcd. for
C42H69O14NPb (%): H, 6.82; C, 49.50; N, 1.37; Pb, 20.33.
Found: H, 6.20; C, 49.61; N, 1.20; Pb, 19.95. The com-
plex is soluble in MeOH, MeCN, CHCl3 and is not solu-
ble in H2O.
1H-NMR (600.13 MHz, δ (assignment),
acetonitrile-d3) 6.19 (18CH), 5.96 (19CH), 4.49 (9CH),
4.34 (20CH), 4.14 (29CH), 3.76 (3CH), 3.71 (25CH),
3.60 (7CH), 3.55 (13CH), 2.84 (10CH), 2.77 (12CH),
2.61 (2CH), 2.17 (22CH2’), 2.04 (27CH2’), 2.02 (26CH2’),
1.95 (23CH2,3 6 C H 2’), 1.93 (22CH2“), 1.92 (5CH2’), 1.90
(4CH2’), 1.76 (6CH), 1.73 (33CH3), 1.71 (14CH), 1.66
(15CH2’), 1.62 (16CH), 1.57 (8CH), 1.47 (27CH2“,
41CH2), 1.45 (5CH2“), 1.43 (41CH2), 1.42 (26CH2“), 1.40
(31CH2), 1.37 (36CH2’), 1.34 (4CH2“), 1.25 (30CH3),
1.15 (15CH2“), 0.94 (42CH3), 0.91 (35CH3,4 0 C H 3), 0.87
(32CH3,3 8 C H 3), 0.76 (39CH3), 0.75 (37CH3), 0.69
(34CH3).
NMR data of sodium salinomycin
The
1H-NMR signals for the starting compound sodium
salinomycin in acetonitrile-d3 are unambiguously
assigned as follows:
1H-NMR (600.13 MHz, δ (assign-
ment), acetonitrile-d3): 6.05 (18CH), 5.79 (19CH), 4.06
(9CH), 4.05 (29CH), 4.02 (20CH), 3.78 (3CH), 3.67
(13CH), 3.63 (7CH), 3.51 (25CH), 2.79 (10CH), 2.77
(2CH), 2.75 (12CH), 2.17 (22CH2“,2 6 C H 2“), 1.94
(22CH2’), 1.90 (23CH2“), 1.88 (36CH2“), 1.86 (4CH2“,
23CH2’), 1.84 (5CH2“), 1.71 (6CH), 1.69 (14CH), 1.67
(15CH2“), 1.62 (16CH, 33CH3), 1.58 (27CH2), 1.43
(5CH2’), 1.40 (4CH2’), 1.42 (8CH), 1.35 (26CH2’), 1.33
(41CH2“), 1.32 (36CH2’), 1.30 (31CH2“), 1.26 (31CH2’),
1.24 (30CH3),1.23 (41CH2’), 1.16 (15CH2’), 0.91
(40CH3), 0.89 (35CH3), 0.87 (32CH3), 0.85 (42CH3),
0.79 (38CH3), 0.76 (37CH3), 0.70 (34CH3, 39CH3).
NMR data of salinomycinic acid
Salinomycinic acid was prepared as previously reported
[29].
1H-NMR (600.13 MHz, δ (assignment), acetoni-
trile-d3): 6.06 (18CH), 5.92 (19CH), 4.09 (9CH), 3.93
(20CH), 3.90 (3CH), 3.72 (29CH), 3.69 (13CH), 3.64
(25CH), 3.60 (7CH), 2.95 (2CH, 10CH), 2.66 (12CH),
2.24 (22CH2“, 23CH2“), 1.88 (22CH2’,4 C H 2“, 36CH2“),
1.85 (5CH2“), 1.80 (6CH), 1.71 (14CH, 23CH2’), 1.70
(26CH2“), 1.61 (27CH2“), 1.59 (16CH), 1.58 (15CH2“),
1.54 (27CH2’), 1.50 (26CH2’), 1.47 (8CH), 1.45 (5CH2’),
1.44 (41CH2,4 C H 2’), 1.42 (36CH2’), 1.36 (33CH3), 1.29
(31CH2), 1.16 (30CH3), 1.12 (15CH2’), 0.94 (40CH3),
0.91 (42CH3), 0.86 (35CH3), 0.85 (32CH3), 0.79
(37CH3), 0.77 (38CH3), 0.73 (39CH3), 0.69 (34CH3).
Additional material
Additional file 1: Supplementary figure 1. Edited HSQC spectrum of
complex 1.
Additional file 2: Supplementary figure 2. Edited HSQC spectrum of
complex 2.
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